Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
272 participants
INTERVENTIONAL
2014-04-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Furthermore patients with depression will receive Online Therapy for depression. Aim of this part of the study is to investigate whether quality of life changes accordingly to improvement of symptoms after online therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Inpatient Psychotherapeutic Treatment With Online Self-help : Acceptance and Efficacy
NCT02196896
Mobile Sensing and Support for Depression
NCT02776839
Evaluation of the Effectiveness of a Web-based Treatment Program for Depression for the Reduction of Depressive Symptoms
NCT01401296
Increasing Cost-effectiveness of Inpatient Treatment of Affective Disorders
NCT00662428
Internet Program for Workers With Subthreshold Depression
NCT02335554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* After screening: patients which meet inclusion criteria and no exclusion criteria can take part in online therapy for depression.
* After 12 weeks 2nd online survey. After this survey patients can use the program the following 6 months (follow-up)
* After 6 months 3rd and last online-survey.
* According to the aims of the study cross-sectional as well as longitudinal data will be obtained and analysed
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no mail support
no mail support during follow-up
no mail support
follow-up without mail support
mail support
Mail support
between post treatment and follow up two groups: one with unspecific mail support every 2 weeks one without
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mail support
between post treatment and follow up two groups: one with unspecific mail support every 2 weeks one without
no mail support
follow-up without mail support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* depression at least slight according BDI (Beck depression inventory) and at least 2 weeks
Exclusion Criteria
* suicidal ideation
* alcohol or drug dependency
* history of psychotic symptoms
* history of bipolar disorder or previous mania
* current in-patient care or semi-residential treatment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Makora
UNKNOWN
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S Weidt, MD
Role: PRINCIPAL_INVESTIGATOR
USZ, UZH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich - only online recruitment
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-0542
Identifier Type: OTHER
Identifier Source: secondary_id
ICBT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.